Advanced Vision Therapies, Inc Company Profile

12:54 EDT 21st March 2018 | BioPortfolio

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a multi-billion dollar magnitude, and represents significant unmet medical needs, has been underserved by large pharma. Recent clinical trial data suggest that these diseases will be treatable, but with therapeutics that must be repeatedly injected directly into the eyes. AVT recognized that an improved delivery system is required to enable the broad application of ocular therapeutics. The company has identified two novel therapeutics and developed a proprietary delivery system, which, with a single administration, will provide sustained, possibly life-long therapy. The AVT business model is to leverage its expertise and that of its collaborators to rapidly advance its first product candidate into the clinic and then form a partnership with large pharma for late stage clinical trials, product launch, and marketing.


9700 Great Seneca Highway
United States of America


Phone: 240-453-8478
Fax: 240-453-6208

News Articles [853 Associated News Articles listed on BioPortfolio]

Autolus announces support of NAATTC and iMATCH to facilitate development of advanced therapies

UK-based biopharmaceutical company, Autolus, has announced its participation in the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) and support of the Innovate Manchester Advanced Thera...

This Gene Therapy for Vision Loss is Safe and Effective After Two Years

The results of a long-term follow-up suggest that GenSight’s gene therapy for Leber hereditary optic neuropathy can provide safe and effective treatment for the genetic cause of vision loss. Gen...

EBE and EFPIA call for improved transparency on exemptions for advanced therapies

The European Biopharmaceutical Enterprises (EBE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have issued a statement calling on the EC to improve transparency on hosp...

The LASIK Vision Institute Announces New Center in Tinley Park, IL

The LASIK Vision Institute (LVI) is proud to announce the opening of our brand-new LASIK eye surgery facility located in Tinley Park, Illinois. Also serving the community of Orland Park, this new cen...

Precision oncology may improve overall survival, lower healthcare costs for advanced cancer patients

The use of advanced molecular diagnostic technologies, such as Next-Generation Sequencing-based gene panel testing, to select targeted therapies in advanced cancer patients is known as precision oncol...

Autolus to support UK network of Advanced Therapies Treatment Centres

The post Autolus to support UK network of Advanced Therapies Treatment Centres appeared first on SynBioBeta.

Young woman presents with acute-onset unilateral vision loss

A 27-year-old marketing professional was seen at Tufts Medical Center emergency department with new-onset vision changes in the right eye. She first noted a change in vision approximately 30 hours bef...

Pixium Vision (PIX) - Pixium cleared to start EU Prima feasibility study

Edison Investment Research - Pharmaceutical & healthcare - Pixium Vision: Pixium has received clearance from the French regulatory agency (Agence Nationale de Sécurité du Médicame...

PubMed Articles [1818 Associated PubMed Articles listed on BioPortfolio]

Clinical Decision Support to Effeciently Identify Patients Eligible for Advanced Heart Failure Therapies.

Patients who need and receive timely advanced heart failure (HF) therapies have better long-term survival. However, many of these patients are not identified and referred as soon as possible.

Funding breakthrough therapies: A systematic review and recommendation.

Advanced therapy medicinal products (ATMPs) are innovative therapies likely associated with high prices. Payers need guidance to create a balance between ensuring patient access to breakthrough therap...

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies.

Pancreatic cancer is typically characterized by its aggressive tumor growth and dismal prognosis. Approximately 30% of patients with pancreatic cancer present with locally advanced disease, broadly de...

The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer.

A recently discovered mechanism enabling prostate cancer cells to escape the effects of endocrine therapies consists in the synthesis of C-terminally truncated, constitutively active androgen receptor...

Assessment of an Advanced Vision Screener in the Detection of Amblyopia in the Nebraska Pediatric Population.

To determine the validity of the OPTEC 5500 vision screener (Stereo Optical Co., Inc., Chicago, IL) in assessing visual acuity and amblyopia in pediatric patients between the ages of 3 and 17 years by...

Clinical Trials [6277 Associated Clinical Trials listed on BioPortfolio]

Low-vision Rehabilitation Program for Low-vision Patients and Care Givers

To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).

Low Vision Intervention Trial II (LOVIT II)

This study will determine if the interdisciplinary team low vision rehabilitation program is more effective than basic low vision care provided by an optometrist working alone in improving...

Safety Study Looking at the Effects of Stendra on Vision

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a slowly progressive retinal degeneration for which there is no proven treatment. Patients are interested in trying alternative therapies to try to reduce thei...

VA Low Vision Intervention Trial

The primary purpose of this research study is to evaluate the effectiveness of a new outpatient low vision rehabilitation program that is targeted to serve legally blind veterans with cent...

Companies [2312 Associated Companies listed on BioPortfolio]

Xcovery Vision

Xcovery Vision is an ophthalmology-focused subsidiary of Xcovery Holding, a clinical-stage company developing novel therapies for cancer and inflammatory diseases. Xcovery Vision'...

RetroSense Therapeutics

RetroSense Therapeutics is a biotechnology company developing a game-changing gene therapy to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) ...

RetroSense Therapeutics, LLC

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to r...

Carl Zeiss Vision

Carl Zeiss Vision ( is a global leader in precision optics. With a full line of advanced customized lenses, advanced performance coatings, i.Scription® by ...

Advanced Vision Therapies, Inc

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a m...

More Information about "Advanced Vision Therapies, Inc" on BioPortfolio

We have published hundreds of Advanced Vision Therapies, Inc news stories on BioPortfolio along with dozens of Advanced Vision Therapies, Inc Clinical Trials and PubMed Articles about Advanced Vision Therapies, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Vision Therapies, Inc Companies in our database. You can also find out about relevant Advanced Vision Therapies, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record